0001127602-18-036235.txt : 20181213
0001127602-18-036235.hdr.sgml : 20181213
20181213183033
ACCESSION NUMBER: 0001127602-18-036235
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181212
FILED AS OF DATE: 20181213
DATE AS OF CHANGE: 20181213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANSTICE DAVID W
CENTRAL INDEX KEY: 0001181171
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 181234207
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-12-12
0001520262
Alkermes plc.
ALKS
0001181171
ANSTICE DAVID W
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN 4 IRELAND
1
Ordinary Shares
2018-12-12
4
M
0
15000
8.98
A
70000
D
Ordinary Shares
2018-12-12
4
S
0
3552
35.608
D
66448
D
Ordinary Shares
2018-12-12
4
S
0
235
35.9218
D
66213
D
Ordinary Shares
2018-12-12
4
M
0
5000
8.98
A
71213
D
Ordinary Shares
2018-12-12
4
S
0
5000
35.5578
D
66213
D
Non Qualified Stock Option (Right to Buy)
8.98
2018-12-12
4
M
0
15000
0
D
2019-10-06
Ordinary Shares
15000
5000
D
Non Qualified Stock Option (Right to Buy)
8.98
2018-12-12
4
M
0
5000
0
D
2019-10-06
Ordinary Shares
5000
0
D
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.885 to $35.87. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.88 to $35.99. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.87 to $35.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
These options are fully vested in accordance with their terms.
/s/ Jennifer Baptiste, attorney-in-fact for David W. Anstice
2018-12-13